Trafalgar International GCAN
OTC GCAN
$0.35 +0.00 (+0.00%)
At close: Sep 8, 2026 · 4:00 PM EDT

Trafalgar International (GCAN) Liabilities and Shareholders Equity (2017 - 2026)

Trafalgar International (GCAN) posted Liabilities and Shareholders Equity of $1439.0 for Q1 2026, up 76.56% on a QoQ basis from $815.0 in Q4 2025, and down 96.89% year-over-year from $46213.0 in Q1 2025.

Analysis

Trafalgar International (GCAN) Liabilities and Shareholders Equity (2017 - 2026) Analysis & Trends

Trafalgar International has reported Liabilities and Shareholders Equity for 10 years, with the latest figure at $1439.0 in Q1 2026.

  • On a quarterly basis, Liabilities and Shareholders Equity fell 96.89% year-over-year to $1439.0 in Q1 2026; TTM through Mar 2026 was $50321.0, a 79.97% decrease from a year earlier, with the FY2025 full-year figure at $815.0, down 98.59% from the prior year.
  • Liabilities and Shareholders Equity was $1439.0 for Q1 2026 at Trafalgar International, up from $815.0 in the prior quarter.
  • The five-year high for Liabilities and Shareholders Equity was $381756.0 in Q1 2022, with the low at $815.0 in Q4 2025.
  • Average Liabilities and Shareholders Equity over 5 years is $153525.2, with a median of $133490.0 recorded in 2024.
  • The sharpest annual moves came in 2022 and 2025: Liabilities and Shareholders Equity grew 2.45% in 2022, then tumbled 98.59% in 2025.
  • Over 5 years, Liabilities and Shareholders Equity stood at $280447.0 in 2022, then sank by 38.57% to $172276.0 in 2023, then plunged by 66.46% to $57785.0 in 2024, then sank by 98.59% to $815.0 in 2025, then soared by 76.56% to $1439.0 in 2026.
  • The last three Liabilities and Shareholders Equity figures came in at $1439.0 (Q1 2026), $815.0 (Q4 2025), and $21355.0 (Q3 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Liabilities and Shareholders Equity (Qtr)
1 Johnson & Johnson 643.26 Bn 622.50 Bn 17.26 Bn 201.06 Bn
2 AbbVie 443.31 Bn 436.74 Bn 12.70 Bn 135.12 Bn
3 Merck 364.74 Bn 357.60 Bn 12.21 Bn 129.80 Bn
4 Novartis Ag 266.46 Bn 258.77 Bn 11.24 Bn 122.03 Bn
5 Pfizer 158.57 Bn 146.88 Bn 10.94 Bn 201.13 Bn
6 Sanofi 52.33 Bn 44.95 Bn 10.79 Bn 150.01 Bn
7 Revolution Medicines 43.79 Bn 43.79 Bn - 4.32 Bn
8 Incyte 25.23 Bn 20.69 Bn 1.57 Bn 7.87 Bn
9 United Therapeutics 21.67 Bn 19.01 Bn 683.80 Mn 7.22 Bn
10 Trafalgar International 217,335.05 217,335.05 - 1,439.00
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2026 1,439.00
Dec 31, 2025 815.00
Sep 30, 2025 21,355.00
Jun 30, 2025 26,712.00
Mar 31, 2025 46,213.00
Dec 31, 2024 57,785.00
Sep 30, 2024 63,949.00
Jun 30, 2024 83,233.00
Mar 31, 2024 133,490.00
Dec 31, 2023 172,276.00
Sep 30, 2023 206,199.00
Jun 30, 2023 248,664.00
Mar 31, 2023 260,720.00
Dec 31, 2022 280,447.00
Sep 30, 2022 300,761.00
Jun 30, 2022 324,114.00
Mar 31, 2022 381,756.00
Dec 31, 2021 392,937.00
Sep 30, 2021 509,775.00
Jun 30, 2021 583,597.00